Regional differences in the prescription of biologics for psoriasis in Sweden: a register-based study of 4168 patients
PS Calara, R Althin, KS Carlsson, M Schmitt-Egenolf - BioDrugs, 2017 - Springer
Background Observational studies suggest an inequitable prescription of biologics in
psoriasis care, which may be attributed to geographical differences in treatment access …
psoriasis care, which may be attributed to geographical differences in treatment access …
Dose Increase Beyond Labelled Dose of Biologic Treatments In Psoriasis Patients: A Real-World Study In Sweden
K Geale, M Costa-Scharplatz, B Anell… - Value in …, 2017 - valueinhealthjournal.com
Objectives Previous research shows dose increase beyond labelled dose (DIBLD) of
biologic treatments is commonly observed in psoriasis. However, this has not been studied …
biologic treatments is commonly observed in psoriasis. However, this has not been studied …